Sabra Health Care REIT (SBRA) Set to Release Quarterly Earnings

Sabra Health Care REIT (NASDAQ:SBRA) is expected to publish its earnings report after the market closes on Wednesday, February 19th, according to Financial Modeling Prep. Analysts predict that the company will announce earnings of $0.36 per share and a revenue figure reaching $178.01 million for the quarter. Investors interested in the details can register for Sabra's conference call through a provided link.

Stock Performance Overview

As of Wednesday, NASDAQ SBRA opened at $16.24. The company operates with a quick ratio and current ratio both standing at 4.16, indicating a strong liquidity position. Its debt-to-equity ratio is recorded at 0.90. Over the past year, Sabra Health Care REIT has experienced a low of $13.26 and a high of $20.03. Technical indicators show a fifty-day moving average of $17.09 and a 200-day moving average of $17.63. The stock currently holds a market capitalization of $3.84 billion with a price-to-earnings ratio of 39.61, a price-to-earnings-growth ratio of 2.02, and a beta of 1.25.

Dividend Announcement

On another note, the company has declared a quarterly dividend that is set to be paid on Friday, February 28th. Shareholders who are on record by Friday, February 14th, will receive a dividend of $0.30. This totals to an annualized dividend of $1.20, which translates to a yield of 7.39%. The ex-dividend date is also Friday, February 14th, and it’s notable that the company’s payout ratio is significantly high at 292.69%.

Recent Analyst Ratings Changes

Several research analysts have provided updates regarding SBRA shares. Recently, Citizens JMP upgraded Sabra Health Care from a "hold" rating to a "strong-buy" rating in a research note dated January 7th. Mizuho reaffirmed a "neutral" rating with a target price of $20.00 for the stock as of December 5th. However, Truist Financial downgraded Sabra Health Care REIT from "buy" to "hold," adjusting their price target from $18.00 to $17.00 in a report on January 17th. Meanwhile, JMP Securities raised the rating from "market perform" to "outperform," setting a price objective of $20.00. Presently, MarketBeat.com shows a mixed consensus, with three analysts maintaining a hold rating, four assigning buy ratings, and one issuing a strong buy rating. The average price target across analysts stands at $18.86 with a consensus rating of "Moderate Buy."

Company Profile

Sabra Health Care REIT, Inc. specializes in acquiring, financing, and managing healthcare properties. Founded on May 10, 2010, the company has its headquarters located in Tustin, CA.

Important Consideration for Investors

As the earnings announcement approaches, it's essential for potential investors to analyze the company's financial health and market position. While Sabra Health Care REIT currently holds a "Moderate Buy" rating, investors are advised to consider other opportunities as recommended by top analysts.

Earnings, Stocks, Investors